Table 6.
Model Used a | Type of Device b | Reference |
---|---|---|
nHDF cells, SD rats | CZBs | [125] |
PBMC, sheep fibroblast cells | SAGA-ZnO QDs hydrogels | [126] |
HaCaT | CHT/SS/ZnO QDs, CHT/SS/LA | [128] |
rats | CHT/gel/C4S/ZnO films | [129] |
a nHDF: Normal human dermal fibroblasts; SD: Sprague-Dawley; PBMC: Peripheral blood mononuclear cells; HaCaT: Aneuploid immortal keratinocyte cell. b CZBs: Microporous chitosan hydrogel/nano zinc oxide composite bandages; SAGA-ZnO QDs hydrogels; CHT/SS/ZnO QDs: Chitosan/silk sericin scaffolds combined with ZnO QDs; CHT/SS/LA: Chitosan/silk sericin scaffolds combined with lauric acid; CHT/gel/C4S/ZnO films: chitosan-based films containing gelatin, chondroitin 4-Sulphate and ZnO, respectively.